FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083774585> ?p ?o ?g. }

• W2083774585 endingPage "104" @default.
• W2083774585 startingPage "93" @default.
• W2083774585 abstract "While the androgens of testicular origin (representing about 50% of total androgens in men over 50 years) can be completely eliminated by surgical or medical castration with GnRH (gonadotropin-releasing hormone) agonists or antagonists, the antiandrogens currently available as blockers of androgen binding to the androgen receptor (AR), namely bicalutamide (BICA), flutamide (FLU) and nilutamide have too weak affinity to completely neutralize the other 50% of androgens made locally from dehydroepiandrosterone (DHEA) in the prostate cancer tissue by the mechanisms of intracrinology. Series of steroid derivatives having pure and potent antagonistic activity on the human and rodent AR were synthesized. Assays of AR binding and activity in carcinoma mouse Shionogi and human LNCaP cells as well as in vivo bioavailability measurements and in vivo prostate weight assays in the rat were used. The chosen lead steroidal compound, namely EM-5854, has a 3.7-fold higher affinity than BICA for the human AR while EM-5855, an important metabolite of EM-5854, has a 94-fold higher affinity for the human AR compared to BICA. EM-5854 and EM-5855 are 14 times more potent than BICA in inhibiting androgen (R1881)-stimulated prostatic specific antigen (PSA) secretion in human prostatic carcinoma LNCaP cells in vitro. MDV3100 has a potency comparable to bicalutamide in these assays. Depending upon the oral formulation, EM-5854 is 5- to 10-times more potent than BICA to inhibit dihydrotestosterone (DHT)-stimulated ventral prostatic weight in vivo in the rat while MDV3100 has lower activity than BICA in this in vivo model. These data are supported by respective 40-fold and 105-fold higher potencies of EM-5854 and EM-5855 compared to BICA to inhibit cell proliferation in the androgen-sensitive Shionogi carcinoma cell model. Although the present preclinical results data need evaluation in clinical trials in men, combination of the data obtained in vitro in human LNCaP cells as indicator of potency in the human prostate and the data on metabolism evaluated in vivo on ventral prostate weight in the rat, could suggest the possibility of a 70- to 140-fold higher potency of EM-5854 compared to bicalutamide (Casodex) for the treatment of prostate cancer in men." @default.
• W2083774585 created "2016-06-24" @default.
• W2083774585 creator A5028613512 @default.
• W2083774585 creator A5035320857 @default.
• W2083774585 creator A5065560889 @default.
• W2083774585 date "2012-10-01" @default.
• W2083774585 modified "2023-09-25" @default.
• W2083774585 title "Steroid derivatives as pure antagonists of the androgen receptor" @default.
• W2083774585 cites W116367892 @default.
• W2083774585 cites W122252942 @default.
• W2083774585 cites W1565276921 @default.
• W2083774585 cites W1894618651 @default.
• W2083774585 cites W1964741914 @default.
• W2083774585 cites W1966517875 @default.
• W2083774585 cites W1968513785 @default.
• W2083774585 cites W1969498141 @default.
• W2083774585 cites W1970097733 @default.
• W2083774585 cites W1970892554 @default.
• W2083774585 cites W1974810481 @default.
• W2083774585 cites W1978426649 @default.
• W2083774585 cites W1980248434 @default.
• W2083774585 cites W1983806503 @default.
• W2083774585 cites W1985037204 @default.
• W2083774585 cites W1987356926 @default.
• W2083774585 cites W1988807086 @default.
• W2083774585 cites W1992481935 @default.
• W2083774585 cites W1997672552 @default.
• W2083774585 cites W1998726940 @default.
• W2083774585 cites W2000741688 @default.
• W2083774585 cites W2003955264 @default.
• W2083774585 cites W2005958584 @default.
• W2083774585 cites W2007144541 @default.
• W2083774585 cites W2007336029 @default.
• W2083774585 cites W2008498145 @default.
• W2083774585 cites W2013905345 @default.
• W2083774585 cites W2014145760 @default.
• W2083774585 cites W2014445290 @default.
• W2083774585 cites W2022453124 @default.
• W2083774585 cites W2024721102 @default.
• W2083774585 cites W2027602941 @default.
• W2083774585 cites W2030439010 @default.
• W2083774585 cites W2032104148 @default.
• W2083774585 cites W2033621522 @default.
• W2083774585 cites W2037229475 @default.
• W2083774585 cites W2037750383 @default.
• W2083774585 cites W2046631216 @default.
• W2083774585 cites W2049470966 @default.
• W2083774585 cites W2050714175 @default.
• W2083774585 cites W2052420006 @default.
• W2083774585 cites W2054422997 @default.
• W2083774585 cites W2056569366 @default.
• W2083774585 cites W2064602503 @default.
• W2083774585 cites W2066570340 @default.
• W2083774585 cites W2067890225 @default.
• W2083774585 cites W2069791479 @default.
• W2083774585 cites W2071708635 @default.
• W2083774585 cites W2073374104 @default.
• W2083774585 cites W2081365151 @default.
• W2083774585 cites W2084123371 @default.
• W2083774585 cites W2084637523 @default.
• W2083774585 cites W2086158679 @default.
• W2083774585 cites W2086809764 @default.
• W2083774585 cites W2092315209 @default.
• W2083774585 cites W2092629109 @default.
• W2083774585 cites W2101606728 @default.
• W2083774585 cites W2101738855 @default.
• W2083774585 cites W2106559777 @default.
• W2083774585 cites W2119504728 @default.
• W2083774585 cites W2120032813 @default.
• W2083774585 cites W2125437092 @default.
• W2083774585 cites W2132665968 @default.
• W2083774585 cites W2137996608 @default.
• W2083774585 cites W2140313736 @default.
• W2083774585 cites W2151286904 @default.
• W2083774585 cites W2152580800 @default.
• W2083774585 cites W2155622098 @default.
• W2083774585 cites W2160534562 @default.
• W2083774585 cites W2165421358 @default.
• W2083774585 cites W2165782799 @default.
• W2083774585 cites W2276902499 @default.
• W2083774585 cites W2403406646 @default.
• W2083774585 cites W2464502417 @default.
• W2083774585 cites W4246234200 @default.
• W2083774585 cites W4300619205 @default.
• W2083774585 cites W61945152 @default.
• W2083774585 doi "https://doi.org/10.1016/j.jsbmb.2012.02.006" @default.
• W2083774585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22449547" @default.
• W2083774585 hasPublicationYear "2012" @default.
• W2083774585 type Work @default.
• W2083774585 sameAs 2083774585 @default.
• W2083774585 citedByCount "16" @default.
• W2083774585 countsByYear W20837745852013 @default.
• W2083774585 countsByYear W20837745852014 @default.
• W2083774585 countsByYear W20837745852015 @default.
• W2083774585 countsByYear W20837745852016 @default.
• W2083774585 countsByYear W20837745852017 @default.
• W2083774585 countsByYear W20837745852018 @default.
• W2083774585 countsByYear W20837745852019 @default.

• next